improvement

Unveiling the Inaugural Global Protocol Report: A Comprehensive Analysis of Blockchain Protocols that is Poised to Aid WEB3 Decisions

Crypto Oasis, Crypto Valley, the DLT Science Foundation and Inacta Ventures Join Forces in a Groundbreaking Initiative that Will Help Navigate the Blockchain Trilemma Highlights: The report has unprecedented transparency and clarity, granular insights, and an evolving analysis of DLT protocol attributes. It will help industry experts and novices gain foundational knowledge on DLT concepts, WEB3 ecosystem infrastructure, the evolution of the Blockchain landscape, and the role of capital, talent, infrastructure, and regulations in WEB3 innovation. The Global Protocol Report introduces a comprehensive framework for assessing the maturity of DLT

NKGen Biotech Advances Alzheimer’s Treatment with SNK01: First Patient Dosed in Phase 1/2a Trial

December 29, 2023 - NKGen Biotech, Inc. (Nasdaq: NKGN) is making strides in Alzheimer's disease (AD) treatment with the dosing of the first patient in its Phase 1/2a trial for SNK01, an autologous natural killer (NK) cell therapy. The innovative product, designed for moderate AD, has demonstrated promising results in neuroinflammation and cognitive function during its Phase 1 safety trial. Key Points: SNK01 Efficacy: NKGen's SNK01, a cryopreserved autologous NK cell therapy, showed improvement in neuroinflammation and cognitive function in the Phase 1 dose-escalation safety trial. The therapy boasts enhanced

Walking the Tightrope

As we stand on the verge of a new era in crypto, it’s crucial to reaffirm the importance of decentralization. Beyond being a mere aspiration, decentralization serves as the lifeblood of the crypto world, standing as the pivotal force that draws the line between freedom and control. Amidst the hype surrounding the impending approval of a spot Bitcoin ETF in the United States, accompanied by the influx of capital from behemoths like BlackRock, the immediate market surge raises a serious question for the future of crypto. Are people here for

Coya Therapeutics Reports Additional Biomarker and Imaging Data Showing Decrease in Neuroinflammation with COYA 301 in Alzheimer’s Disease.

Highlights Coya reports new data illustrating that administration of COYA 301 (low dose Interleukin-2 (IL-2)) in an open- label study in 8 patients with mild to moderate AD (COYA 301 Trial) resulted in a statistically significant reduction in the expression of three well characterized proinflammatory cytokines -- Tumor Necrosis Factor alpha (TNF-α), Interleukin 6 (IL-6), and Interleukin 1- Beta (IL-1β) -- which correlated with lack of cognitive decline of the patients over the course of the study. TNF-α is one of the main inflammatory cytokines involved in initiating and propagating

Transformational Chief Executive of the United Nations Joint Staff Pension Fund joins Blockchain Conference

Washington, DC - The Government Blockchain Association (GBA) is pleased to announce that Ms. Rosemarie McClean, Chief Executive of the Pension Administration and Assistant Secretary-General of the United Nations, will participate at the upcoming conference, The Future of Money, Governance, and the Law, on May 24-25, 2023, in Washington, DC. Ms. McClean is a seasoned leader in her field, overseeing operations in pensions administration, client services, IT, project management, and process improvement at the United Nations Joint Staff Pension Fund (UNJSPF). She is the Executive Sponsor of a live blockchain

GBA Business Confidence Index increment on record high

Resumption of normal travel boosts business confidence HONG KONG, Apr 17, 2023 - (ACN Newswire) - Standard Chartered and the Hong Kong Trade Development Council (HKTDC) today released the GBA Business Confidence Index (GBAI) for the first quarter of 2023. The current performance for "business confidence" jumped 11.8 points to 51.3, which was also the first above-50 print since the fourth quarter of 2021. The expectations index leapt to 61.5, the 16.4 points jump was the biggest on record since GABI was launched in the second quarter of 2020. The

Malaysian Genomics to Collaborate on Cannabinoid R&D

Group joins MAHSA University and Kensana Health to develop phytopharmaceutical and biotechnology products for commercialisation PETALING JAYA, Malaysia, Feb 24, 2023 - (ACN Newswire) - Malaysian Genomics Resource Centre Berhad, a leading genomics and biopharmaceutical specialist, today announced that the Group has entered into a strategic collaboration with Kensana Health Canada and MAHSA University for the research and development (R&D) of phytopharmaceutical and biotechnology products that can lead to commercialisation. [caption id="attachment_1975874" align="alignnone" width="350"] Dato' Alvin Joseph Nesakumar, Executive Director of Malaysian Genomics[/caption] Kensana Health Canada is a biotechnology specialist

GenTwo Continues Growth Story- New Inflows of Over USD 1 bn

Zurich, 1 February 2023 – _The international securitization specialist GenTwo celebrates its 5th anniversary and looks back on a fast-paced development. In 2022 the number of new products increased by 60% and international business doubled. The business momentum of GenTwo and its subsidiary GenTwo Digital has progressively picked up since the company was founded 5 years ago in February 2018. The products issued on its platform recorded over USD 1 billion in new inflows, resulting in a surge in assets under services growth to USD 2.5 billion as of today,

Breaking New Ground

October has been another strong month for our development team who are continuing to make breakthroughs with the NFT module aspects of Paribus. As we always say it’s never easy to do something that hasn’t been done before, and we’re lucky to have such a talented team of devs conscientiously breaking new ground. Even before our MVP hits the mainnet we’ll be ready to conduct in-house testing of various aspects of our NFT iteration. Frontend This month we’re pleased to announce that several areas of the frontend have completed the

Testing, Testing 3…2…1

Today marks the launch of our MVP on the Goerli testnet, the final phase of testing prior to its official launch. It’s been a busy time for our dev team as nothing in crypto is plain sailing and they’ve done an amazing job of bringing us to this point. (Testnet link located at the bottom of this article) A few weeks ago we launched our MVP to a limited selection of our community on the Rinkeby testnet. However, due to some limitations with Rinkeby, we decided to switch to Goerli